Pharmacogenetics: the outlook for genetic testing in statin therapy.
Chasman
Daniel I
DI
Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA. dchasman@rics.bwh.harvard.edu
Ridker
Paul M
PM
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000037:antagonists & inhibitors; D005821:Genetic Techniques / Q000639:trends*; D014644:Genetic Variation / Q000235:genetics; D005838:Genotype; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D010597:Pharmacogenetics / Q000639:trends; D011110:Polymorphism, Genetic / Q000235:genetics; D012307:Risk Factors
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors